Company: CSCIF
Filing Date: 2025-04-09
Form Type: 20-F
Source: 0001641172-25-003456
Chunk: 1

Company: COSCIENS Biopharma Inc.
Filing Date: 2025-04-09
Form: 20-F
Item: Item 3
Chunk 1
---

Item 3.   Key Information
-------------------------

A.   (Reserved)
---------------

B.   Capitalization and indebtedness
------------------------------------
 
Not applicable.
 

C.   Reasons for the offer and use of proceeds
----------------------------------------------
 
Not applicable.
 

D.   Risk factors
-----------------
 
An investment in our securities involves a high degree of risk. You should carefully consider the risks described below, together with all of the other information included in this Annual Report, before making an investment decision. If any of the following risks actually occur, our business, prospects, financial condition or results of operations could be materially, adversely affected by any of these risks. Additional risks not presently known to us or that we currently deem immaterial may also impair our business operations. The trading price of our securities could decline due to any of these risks, and you may lose all or part of your investment. This Annual Report also contains forward-looking statements that involve risks and uncertainties. Our actual results could differ materially from those anticipated in these forward-looking statements as a result of certain factors, including the risks mentioned below. Forward-looking statements included in this Annual Report are based on information available to us on the date hereof, and all forward-looking statements in the documents incorporated by reference are based on information available to us as of the date of each such document. We undertake no obligation to update or revise any forward-looking statements whether as a result of new information, future events or otherwise, other than as required by applicable law.
 

6
-
Risks Relating to Us and Our Business 
 
Summary of Risk Factors 
 
The following is a summary of the risk factors our business faces. The list below is not exhaustive and investors should read this “Risk Factors” section in full. Some of the risks we face include:

●                                    the delisting of our Common Shares from the NASDAQ or the TSX could                                 
                                                   impact their market price and liquidity;                                              
-----------------------------------------------------------------------------------------------------------------------------------------
●   our ability to continue as a going concern;                                                                                          
●   we may be deemed a passive foreign investment company, which could                                                                   
    result in adverse tax consequences;                                                                                                  
●   our net operating losses may be limited under U.S. tax laws;                                                                         
●   our Rights Plan may prevent changes of control of the Company;                                                                       
    the economic effects of a public health crisis may impact the market                                                                 
    price of our Common Shares;                                                                                                          
●   investments in companies in our industries are generally considered                                                                  
    to be speculative;